Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent &

Clinical Trial Description

A topical agent is applied to suspicious skin lesions and imaged. The images are analyzed to provide a score that correlates with the probability for the presence of melanoma in the lesion. ;

Study Design

Related Conditions & MeSH terms

See also
Status	Clinical Trial	Phase
Terminated	`NCT01486225` - Tolerance Study of the Silicone Bands on Medical Compression Stockings	Phase 4
Recruiting	`NCT03356769` - Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex	Phase 2
Completed	`NCT02009085` - Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.	N/A
Withdrawn	`NCT01385943` - VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine

See also

Status

Clinical Trial

Phase

Terminated

NCT01486225 - Tolerance Study of the Silicone Bands on Medical Compression Stockings

Phase 4

Recruiting

NCT03356769 - Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Phase 2

Completed

NCT02009085 - Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

N/A

Withdrawn

NCT01385943 - VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02056522
Study type	Observational
Source	Orlucent, Inc
Contact
Status	Completed
Phase
Start date	July 2016
Completion date	July 2018

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms